These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10617123)

  • 1. Effect of Congo red on wild-type and mutated prion proteins in cultured cells.
    Milhavet O; Mangé A; Casanova D; Lehmann S
    J Neurochem; 2000 Jan; 74(1):222-30. PubMed ID: 10617123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of amphotericin B on wild-type and mutated prion proteins in cultured cells: putative mechanism of action in transmissible spongiform encephalopathies.
    Mangé A; Milhavet O; McMahon HE; Casanova D; Lehmann S
    J Neurochem; 2000 Feb; 74(2):754-62. PubMed ID: 10646527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro evaluation of the anti-prionic activity of newly synthesized congo red derivatives.
    Poli G; Ponti W; Carcassola G; Ceciliani F; Colombo L; Dall'Ara P; Gervasoni M; Giannino ML; Martino PA; Pollera C; Villa S; Salmona M
    Arzneimittelforschung; 2003; 53(12):875-88. PubMed ID: 14750496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congo red analogues as potential anti-prion agents.
    Villa S; Cignarella G; Barlocco D; Gervasoni M; Carcassola G; Giannino L; Mantegazza P
    Farmaco; 2003 Sep; 58(9):929-37. PubMed ID: 13679188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amphotericin B inhibits the generation of the scrapie isoform of the prion protein in infected cultures.
    Mangé A; Nishida N; Milhavet O; McMahon HE; Casanova D; Lehmann S
    J Virol; 2000 Apr; 74(7):3135-40. PubMed ID: 10708429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anti-prion activity of Congo red. Putative mechanism.
    Caspi S; Halimi M; Yanai A; Sasson SB; Taraboulos A; Gabizon R
    J Biol Chem; 1998 Feb; 273(6):3484-9. PubMed ID: 9452472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of scrapie-associated PrP accumulation. Probing the role of glycosaminoglycans in amyloidogenesis.
    Priola SA; Caughey B
    Mol Neurobiol; 1994; 8(2-3):113-20. PubMed ID: 7999307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent inhibition of scrapie-associated PrP accumulation by congo red.
    Caughey B; Race RE
    J Neurochem; 1992 Aug; 59(2):768-71. PubMed ID: 1352803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A wild-type prion protein does not acquire properties of the scrapie isoform when coexpressed with a mutant prion protein in cultured cells.
    Lehmann S; Daude N; Harris DA
    Brain Res Mol Brain Res; 1997 Dec; 52(1):139-45. PubMed ID: 9450686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural aspects of Congo red as an inhibitor of protease-resistant prion protein formation.
    Demaimay R; Harper J; Gordon H; Weaver D; Chesebro B; Caughey B
    J Neurochem; 1998 Dec; 71(6):2534-41. PubMed ID: 9832153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prion Protein Devoid of the Octapeptide Repeat Region Delays Bovine Spongiform Encephalopathy Pathogenesis in Mice.
    Hara H; Miyata H; Das NR; Chida J; Yoshimochi T; Uchiyama K; Watanabe H; Kondoh G; Yokoyama T; Sakaguchi S
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prion encephalopathies of animals and humans.
    Prusiner SB
    Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxorubicin and congo red effectiveness on prion infectivity in golden Syrian hamster.
    Corato M; Ogliari P; Ceciliani F; Cova E; Bellotti V; Cereda C; Merlini G; Ceroni M
    Anticancer Res; 2009 Jul; 29(7):2507-12. PubMed ID: 19596920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie.
    Fischer M; Rülicke T; Raeber A; Sailer A; Moser M; Oesch B; Brandner S; Aguzzi A; Weissmann C
    EMBO J; 1996 Mar; 15(6):1255-64. PubMed ID: 8635458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggregation of cellular prion protein is initiated by proximity-induced dimerization.
    Goggin K; Bissonnette C; Grenier C; Volkov L; Roucou X
    J Neurochem; 2007 Aug; 102(4):1195-205. PubMed ID: 17663754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prion protein with an E200K mutation displays properties similar to those of the cellular isoform PrP(C).
    Rosenmann H; Talmor G; Halimi M; Yanai A; Gabizon R; Meiner Z
    J Neurochem; 2001 Mar; 76(6):1654-62. PubMed ID: 11259483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prion protein and the scrapie agent: in vitro studies in infected neuroblastoma cells.
    Priola SA; Caughey B; Raymond GJ; Chesebro B
    Infect Agents Dis; 1994; 3(2-3):54-8. PubMed ID: 7812655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical Characterization of Prions.
    Fiorini M; Bongianni M; Monaco S; Zanusso G
    Prog Mol Biol Transl Sci; 2017; 150():389-407. PubMed ID: 28838671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversion of prion protein conformational changes by synthetic beta-sheet breaker peptides.
    Soto C; Kascsak RJ; Saborío GP; Aucouturier P; Wisniewski T; Prelli F; Kascsak R; Mendez E; Harris DA; Ironside J; Tagliavini F; Carp RI; Frangione B
    Lancet; 2000 Jan; 355(9199):192-7. PubMed ID: 10675119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal properties of prion protein with insertional mutations in different cell types.
    Priola SA; Chesebro B
    J Biol Chem; 1998 May; 273(19):11980-5. PubMed ID: 9565627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.